Decline in serumandrogens and survival in metastatic castration resistant prostate cancer (mCRPC) patients treated with docetaxel and prednisone: results from CALGB 90401 (Alliance)   

Ryan, Charles J ,  Dutta, Sandipan ,  Kelly, William K ,  Russell, Carly ... -  EAU   -  Eur Urol   -  2018    

Abstract -  Secondary-not-in-original -  Primary -  GU -  CALGB-90401